Adductor Canal Nerve Versus Femoral Nerve Blockade for Pain Control and Quadriceps Function Following Anterior Cruciate Ligament Reconstruction With Patellar Tendon Autograft: A Prospective Randomized Trial

Autor: Thanos Papavasiliou, Mark Elliott, Lane Bailey, Walter R. Lowe, Christopher D. Harner, Jennifer N. Wu, Joshua Griffin
Rok vydání: 2018
Předmět:
musculoskeletal diseases
Straight leg raise
Adult
Male
medicine.medical_specialty
Anterior cruciate ligament reconstruction
Adolescent
Knee Joint
Adductor canal
medicine.medical_treatment
Anterior cruciate ligament
Electromyography
Transplantation
Autologous

Clonidine
Quadriceps Muscle
03 medical and health sciences
Young Adult
0302 clinical medicine
Femoral nerve
Anesthesia
Conduction

Patellar Ligament
Medicine
Humans
Pain Management
Orthopedics and Sports Medicine
Ropivacaine
Prospective Studies
Range of Motion
Articular

Autografts
030222 orthopedics
Analgesics
Analysis of Variance
Pain
Postoperative

medicine.diagnostic_test
Anterior Cruciate Ligament Reconstruction
business.industry
Nerve Block
030229 sport sciences
Middle Aged
musculoskeletal system
Surgery
Transplantation
medicine.anatomical_structure
Female
business
Range of motion
Femoral Nerve
Zdroj: Arthroscopy : the journal of arthroscopicrelated surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 35(3)
ISSN: 1526-3231
Popis: To compare femoral nerve blockade (FNB) versus adductor canal nerve blockade (ACB) for postoperative pain control and quadriceps muscle function in patients undergoing anterior cruciate ligament (ACL) reconstruction with patellar tendon autograft.A randomized therapeutic trial of 90 patients undergoing ACL reconstruction with patellar tendon autograft was conducted comparing ACB versus FNB at 24 hours, 2 and 4 weeks, and 6 months postsurgery. Early outcome measures included average pain score and morphine equivalent units (milligrams) consumed, quadriceps surface electromyography, straight leg raise, and ability to ambulate without assistive devices. The 6-month outcome measures included knee range of motion (ROM), isokinetic knee extension peak torque, single-leg squat, and single-leg hop performance. Complications were recorded throughout the study for the development of anterior knee pain, knee extension ROM loss, deep vein thrombosis, and graft failure. Mixed-model analysis of variance and Mann-Whitney U tests were performed using an alpha of .05.Quadriceps surface electromyography deficits were higher for FNB at 24 hours (P.001) and 2 weeks (P.001) when compared with the ACB group. There were no between-groups difference for subjective pain (P = .793) or morphine consumption (P = .358) within the first 24 hours of surgery. A higher percentage of patients in the ACB group met the full ambulation criteria at 4 weeks compared with the FNB group (100% vs 84.2%, P.001). No between-group differences were observed at 6 months; however, the rate of knee extension ROM loss was higher for the FNB group versus the ACB group (21.1% vs 5.0%, P = .026), respectively.ACB was as effective as FNB at providing pain control while eliciting fewer quadriceps muscle activation deficits and fewer postoperative complications. Based on previous evidence and the results of this study, we recommend the use of ACB over FNB for the analgesic management of patients undergoing ACL reconstruction with patellar tendon autograft.Level I, prospective randomized controlled trial.
Databáze: OpenAIRE